Re: Lin et al.: Dexamethasone intracanalicular insert for clinically significant aqueous-deficient dry eye: a randomized controlled trial ( Ophthalmology . 2024;131:1033-1044)

被引：0
|
作者：
Hou, Feifei [1 ]
Liu, Guangsen [2 ]
机构：
[1] Yantai Zhengda Guangming Eye Hosp, Dept Ophthalmol, Yantai 264000, Peoples R China
[2] Yantai Zhengda Guangming Eye Hosp, Zhengda Guangming Eye Grp, Dept Ophthalmol, Yantai 264000, Peoples R China
来源：
OPHTHALMOLOGY | 2025年 / 132卷 / 02期
关键词：
D O I：
10.1016/j.ophtha.2024.10.013
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：e19 / e20
页数：2
相关论文
共 5 条
  • [1] Re: Lin et al.: Dexamethasone intracanalicular insert for clinically significant aqueous-deficient dry eye: a randomized controlled trial Reply
    Lin, Michael x.
    Akpek, Esen k.
    OPHTHALMOLOGY, 2025, 132 (02) : e20 - e20
  • [2] Dexamethasone Intracanalicular Insert for Clinically Significant fi cant Aqueous-Deficient Dry Eye A Randomized Controlled Trial
    Lin, Michael X.
    Guo, Lee
    Saldanha, Ian J.
    VanCourt, Shanna
    Zeng, Julia
    Karakus, Sezen
    Hessen, Michelle
    Li, Gavin
    Akpek, Esen K.
    OPHTHALMOLOGY, 2024, 131 (09) : 1033 - 1044
  • [3] Re: Pinto-Fraga et al.: Topical fluorometholone protects the ocular surface of dry eye patients from desiccating stress: a randomized controlled clinical trial (Ophthalmology 2016;123:141-153)
    Estevez, Jose
    Moptom, Bmedsci
    Pesudovs, Konrad
    OPHTHALMOLOGY, 2017, 124 (02) : E14 - E14
  • [4] Re: Boyer et al.: Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema (Ophthalmology 2014;121:1904-14)
    Ziemssen, Focke
    Agostini, Hansjuergen
    OPHTHALMOLOGY, 2015, 122 (03) : E20 - E21
  • [5] Re: Zander et al.: Hyperosmolar eye drops for diurnal corneal edema in Fuchs' endothelial dystrophy: a double-masked randomized controlled trial (Ophthalmology. 2021;128:1527-1533)
    Hoffart, Louis
    OPHTHALMOLOGY, 2022, 129 (09) : E84 - E84
1